+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Active Pharmaceutical Ingredients/API - Market Analysis, Trends, and Forecasts

  • ID: 4804526
  • Report
  • February 2020
  • Region: Global
  • 172 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • ABBVIE
  • ALBEMARLE CORPORATION
  • APOTEX, INC.
  • AUROBINDO PHARMA LIMITED
  • BAYER AG
  • BIOVECTRA
  • MORE
Active Pharmaceutical Ingredients/API market worldwide is projected to grow by US$85.7 Billion, driven by a compounded growth of 5.9%. Innovative, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$102 Billion by the year 2025, Innovative will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$4 Billion to the region's size and clout in the next 5 to 6 years. Over US$4 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Innovative will reach a market size of US$8.9 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5.8% over the next couple of years and add approximately US$14.9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Pfizer, Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • ABBVIE
  • ALBEMARLE CORPORATION
  • APOTEX, INC.
  • AUROBINDO PHARMA LIMITED
  • BAYER AG
  • BIOVECTRA
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Active Pharmaceutical Ingredients: An Overview

Rapid Growth of Healthcare Industry Drives Demand for API

Global Competitor Market Shares

Active Pharmaceutical Ingredients/API Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Factors Influencing the Demand of Active Pharmaceutical Ingredients

Gene-Editing – New Techniques Emerging within the Biologics Industry

API-in-Capsule Fast-Tracking Drug Development Process

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Active Pharmaceutical Ingredients/API Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Active Pharmaceutical Ingredients/API Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Active Pharmaceutical Ingredients/API Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Innovative (Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Innovative (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Innovative (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Generic (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Generic (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Generic (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Captive (Manufacturer) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Captive (Manufacturer) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Captive (Manufacturer) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Merchant (Manufacturer) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Merchant (Manufacturer) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Merchant (Manufacturer) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Synthetic (Synthesis) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Synthetic (Synthesis) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Synthetic (Synthesis) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Biotech (Synthesis) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025

TABLE 20: Biotech (Synthesis) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 21: Biotech (Synthesis) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Active Pharmaceutical Ingredients/API Market Share (in %) by Company: 2019 & 2025

Market Analytics

TABLE 22: United States Active Pharmaceutical Ingredients/API Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 23: Active Pharmaceutical Ingredients/API Market in the United States by Type: A Historic Review in US$ Million for 2009-2017

TABLE 24: United States Active Pharmaceutical Ingredients/API Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 25: United States Active Pharmaceutical Ingredients/API Market Estimates and Projections in US$ Million by Manufacturer: 2018 to 2025

TABLE 26: Active Pharmaceutical Ingredients/API Market in the United States by Manufacturer: A Historic Review in US$ Million for 2009-2017

TABLE 27: United States Active Pharmaceutical Ingredients/API Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025

TABLE 28: United States Active Pharmaceutical Ingredients/API Market Estimates and Projections in US$ Million by Synthesis: 2018 to 2025

TABLE 29: Active Pharmaceutical Ingredients/API Market in the United States by Synthesis: A Historic Review in US$ Million for 2009-2017

TABLE 30: United States Active Pharmaceutical Ingredients/API Market Share Breakdown by Synthesis: 2009 VS 2019 VS 2025

CANADA

TABLE 31: Canadian Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 32: Canadian Active Pharmaceutical Ingredients/API Historic Market Review by Type in US$ Million: 2009-2017

TABLE 33: Active Pharmaceutical Ingredients/API Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 34: Canadian Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Manufacturer: 2018 to 2025

TABLE 35: Canadian Active Pharmaceutical Ingredients/API Historic Market Review by Manufacturer in US$ Million: 2009-2017

TABLE 36: Active Pharmaceutical Ingredients/API Market in Canada: Percentage Share Breakdown of Sales by Manufacturer for 2009, 2019, and 2025

TABLE 37: Canadian Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Synthesis: 2018 to 2025

TABLE 38: Canadian Active Pharmaceutical Ingredients/API Historic Market Review by Synthesis in US$ Million: 2009-2017

TABLE 39: Active Pharmaceutical Ingredients/API Market in Canada: Percentage Share Breakdown of Sales by Synthesis for 2009, 2019, and 2025

JAPAN

TABLE 40: Japanese Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 41: Active Pharmaceutical Ingredients/API Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 42: Japanese Active Pharmaceutical Ingredients/API Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 43: Japanese Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Manufacturer for the Period 2018-2025

TABLE 44: Active Pharmaceutical Ingredients/API Market in Japan: Historic Sales Analysis in US$ Million by Manufacturer for the Period 2009-2017

TABLE 45: Japanese Active Pharmaceutical Ingredients/API Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025

TABLE 46: Japanese Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Synthesis for the Period 2018-2025

TABLE 47: Active Pharmaceutical Ingredients/API Market in Japan: Historic Sales Analysis in US$ Million by Synthesis for the Period 2009-2017

TABLE 48: Japanese Active Pharmaceutical Ingredients/API Market Share Analysis by Synthesis: 2009 VS 2019 VS 2025

CHINA

TABLE 49: Chinese Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 50: Active Pharmaceutical Ingredients/API Historic Market Analysis in China in US$ Million by Type: 2009-2017

TABLE 51: Chinese Active Pharmaceutical Ingredients/API Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 52: Chinese Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Manufacturer for the Period 2018-2025

TABLE 53: Active Pharmaceutical Ingredients/API Historic Market Analysis in China in US$ Million by Manufacturer: 2009-2017

TABLE 54: Chinese Active Pharmaceutical Ingredients/API Market by Manufacturer: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 55: Chinese Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Synthesis for the Period 2018-2025

TABLE 56: Active Pharmaceutical Ingredients/API Historic Market Analysis in China in US$ Million by Synthesis: 2009-2017

TABLE 57: Chinese Active Pharmaceutical Ingredients/API Market by Synthesis: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Active Pharmaceutical Ingredients/API Market: Competitor Market Share Scenario (in %) for 2019 & 2025

API Supply Chain Overview

Market Analytics

TABLE 58: European Active Pharmaceutical Ingredients/API Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 59: Active Pharmaceutical Ingredients/API Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 60: European Active Pharmaceutical Ingredients/API Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 61: European Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 62: Active Pharmaceutical Ingredients/API Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 63: European Active Pharmaceutical Ingredients/API Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 64: European Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Manufacturer: 2018-2025

TABLE 65: Active Pharmaceutical Ingredients/API Market in Europe in US$ Million by Manufacturer: A Historic Review for the Period 2009-2017

TABLE 66: European Active Pharmaceutical Ingredients/API Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025

TABLE 67: European Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Synthesis: 2018-2025

TABLE 68: Active Pharmaceutical Ingredients/API Market in Europe in US$ Million by Synthesis: A Historic Review for the Period 2009-2017

TABLE 69: European Active Pharmaceutical Ingredients/API Market Share Breakdown by Synthesis: 2009 VS 2019 VS 2025

FRANCE

TABLE 70: Active Pharmaceutical Ingredients/API Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 71: French Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 72: French Active Pharmaceutical Ingredients/API Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 73: Active Pharmaceutical Ingredients/API Market in France by Manufacturer: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 74: French Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Manufacturer: 2009-2017

TABLE 75: French Active Pharmaceutical Ingredients/API Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025

TABLE 76: Active Pharmaceutical Ingredients/API Market in France by Synthesis: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 77: French Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Synthesis: 2009-2017

TABLE 78: French Active Pharmaceutical Ingredients/API Market Share Analysis by Synthesis: 2009 VS 2019 VS 2025

GERMANY

TABLE 79: Active Pharmaceutical Ingredients/API Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 80: German Active Pharmaceutical Ingredients/API Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 81: German Active Pharmaceutical Ingredients/API Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 82: Active Pharmaceutical Ingredients/API Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Manufacturer for the Period 2018-2025

TABLE 83: German Active Pharmaceutical Ingredients/API Historic Market Analysis in US$ Million by Manufacturer: 2009-2017

TABLE 84: German Active Pharmaceutical Ingredients/API Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025

TABLE 85: Active Pharmaceutical Ingredients/API Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Synthesis for the Period 2018-2025

TABLE 86: German Active Pharmaceutical Ingredients/API Historic Market Analysis in US$ Million by Synthesis: 2009-2017

TABLE 87: German Active Pharmaceutical Ingredients/API Market Share Breakdown by Synthesis: 2009 VS 2019 VS 2025

ITALY

TABLE 88: Italian Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 89: Active Pharmaceutical Ingredients/API Historic Market Analysis in Italy in US$ Million by Type: 2009-2017

TABLE 90: Italian Active Pharmaceutical Ingredients/API Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 91: Italian Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Manufacturer for the Period 2018-2025

TABLE 92: Active Pharmaceutical Ingredients/API Historic Market Analysis in Italy in US$ Million by Manufacturer: 2009-2017

TABLE 93: Italian Active Pharmaceutical Ingredients/API Market by Manufacturer: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 94: Italian Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Synthesis for the Period 2018-2025

TABLE 95: Active Pharmaceutical Ingredients/API Historic Market Analysis in Italy in US$ Million by Synthesis: 2009-2017

TABLE 96: Italian Active Pharmaceutical Ingredients/API Market by Synthesis: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 97: United Kingdom Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 98: Active Pharmaceutical Ingredients/API Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 99: United Kingdom Active Pharmaceutical Ingredients/API Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 100: United Kingdom Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Manufacturer for the Period 2018-2025

TABLE 101: Active Pharmaceutical Ingredients/API Market in the United Kingdom: Historic Sales Analysis in US$ Million by Manufacturer for the Period 2009-2017

TABLE 102: United Kingdom Active Pharmaceutical Ingredients/API Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025

TABLE 103: United Kingdom Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Synthesis for the Period 2018-2025

TABLE 104: Active Pharmaceutical Ingredients/API Market in the United Kingdom: Historic Sales Analysis in US$ Million by Synthesis for the Period 2009-2017

TABLE 105: United Kingdom Active Pharmaceutical Ingredients/API Market Share Analysis by Synthesis: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 106: Rest of Europe Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 107: Active Pharmaceutical Ingredients/API Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 108: Rest of Europe Active Pharmaceutical Ingredients/API Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 109: Rest of Europe Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Manufacturer: 2018-2025

TABLE 110: Active Pharmaceutical Ingredients/API Market in Rest of Europe in US$ Million by Manufacturer: A Historic Review for the Period 2009-2017

TABLE 111: Rest of Europe Active Pharmaceutical Ingredients/API Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025

TABLE 112: Rest of Europe Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Synthesis: 2018-2025

TABLE 113: Active Pharmaceutical Ingredients/API Market in Rest of Europe in US$ Million by Synthesis: A Historic Review for the Period 2009-2017

TABLE 114: Rest of Europe Active Pharmaceutical Ingredients/API Market Share Breakdown by Synthesis: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 115: Active Pharmaceutical Ingredients/API Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 116: Asia-Pacific Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 117: Asia-Pacific Active Pharmaceutical Ingredients/API Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 118: Active Pharmaceutical Ingredients/API Market in Asia-Pacific by Manufacturer: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 119: Asia-Pacific Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Manufacturer: 2009-2017

TABLE 120: Asia-Pacific Active Pharmaceutical Ingredients/API Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025

TABLE 121: Active Pharmaceutical Ingredients/API Market in Asia-Pacific by Synthesis: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 122: Asia-Pacific Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Synthesis: 2009-2017

TABLE 123: Asia-Pacific Active Pharmaceutical Ingredients/API Market Share Analysis by Synthesis: 2009 VS 2019 VS 2025

REST OF WORLD

TABLE 124: Rest of World Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 125: Rest of World Active Pharmaceutical Ingredients/API Historic Market Review by Type in US$ Million: 2009-2017

TABLE 126: Active Pharmaceutical Ingredients/API Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 127: Rest of World Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Manufacturer: 2018 to 2025

TABLE 128: Rest of World Active Pharmaceutical Ingredients/API Historic Market Review by Manufacturer in US$ Million: 2009-2017

TABLE 129: Active Pharmaceutical Ingredients/API Market in Rest of World: Percentage Share Breakdown of Sales by Manufacturer for 2009, 2019, and 2025

TABLE 130: Rest of World Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Synthesis: 2018 to 2025

TABLE 131: Rest of World Active Pharmaceutical Ingredients/API Historic Market Review by Synthesis in US$ Million: 2009-2017

TABLE 132: Active Pharmaceutical Ingredients/API Market in Rest of World: Percentage Share Breakdown of Sales by Synthesis for 2009, 2019, and 2025

IV. COMPETITION

ABBVIE

ALBANY MOLECULAR RESEARCH

ALBEMARLE CORPORATION

ALMAC GROUP

APOTEX, INC.

AUROBINDO PHARMA LIMITED

ASTRAZENECA PLC

BASF SE

BAYER AG

BCN PEPTIDES S.A.

BIOVECTRA

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

BRISTOL-MYERS SQUIBB COMPANY

CAMBREX CORPORATION

CIPLA LIMITED

CORDENPHARMA INTERNATIONAL

DALTON PHARMA SERVICES

DISHMAN GROUP

DR. REDDY'S LABORATORIES LTD.

ELI LILLY AND COMPANY

F. HOFFMANN-LA ROCHE AG

GLAXOSMITHKLINE PLC

JOHNSON MATTHEY PLC

JSC GRINDEKS

LUPIN LIMITED

LUPIN PHARMACEUTICALS, INC.

MIDAS PHARMA GMBH

MYLAN NV

NOVARTIS AG

NOVASEP HOLDING SAS

PFANSTIEHL

PFIZER

PFIZER CENTREONE

POLYPEPTIDE GROUP

REGIS TECHNOLOGIES, INC.

SANECA PHARMACEUTICALS, A.S.

SANOFI SA

SIEGFRIED AG

SUN PHARMACEUTICAL INDUSTRIES LIMITED

TEVA PHARMACEUTICAL INDUSTRIES

DOLDER AG

FARMABIOS SPA

FARMHISPANIA GROUP

FERMION OY

GLYCOSYN

MOLCAN CORPORATION

NORAMCO, INC.

OLON S.P.A.

STEROID S.P.A.

SYMBIOTEC PHARMA LAB PVT. LTD.

AMBIOPHARM, INC.

ASYMCHEM INC.

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • ABBVIE
  • ALBANY MOLECULAR RESEARCH
  • ALBEMARLE CORPORATION
  • ALMAC GROUP
  • APOTEX, INC.
  • AUROBINDO PHARMA LIMITED
  • ASTRAZENECA PLC
  • BASF SE
  • BAYER AG
  • BCN PEPTIDES S.A.
  • BIOVECTRA
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BRISTOL-MY
Note: Product cover images may vary from those shown
Adroll
adroll